Ajanta Pharma

Sector: Healthcare

Followers

0
0
2
2
.
0
0
9
9
7
7
,
2
2
-37.40 (-1.32%)

As on 17 Apr, 2026 | 15:59

Open Trading A/c
Day Range
2,782.60
2,865.90
LH
52 Week Range
2,329.90
3,228.00
LH
Volume
* i
Bid / Ask
114,553.00
0.00 / 0.00

Ajanta Pharma Announcements

Pls find enclosed herewith Certificate under Reg. 74(5) of SEBI (DP) Regulations.

06 Apr, 2026 | 02:06pm • Source: BSE

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 03, 2026 for...

04 Apr, 2026 | 04:24pm • Source: BSE

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Ajanta...

01 Apr, 2026 | 02:37pm • Source: BSE

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 31, 2026 for...

01 Apr, 2026 | 10:17am • Source: BSE

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 27, 2026 for...

27 Mar, 2026 | 05:27pm • Source: BSE

Please find enclosed herewith intimation w.r.t Closure of Trading Window

26 Mar, 2026 | 09:43am • Source: BSE

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 23, 2026 for...

23 Mar, 2026 | 06:36pm • Source: BSE

Pls find enclosed intimation w.r.t Participation in Investor Conference.

09 Mar, 2026 | 08:44am • Source: BSE

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 06, 2026 for...

06 Mar, 2026 | 12:36pm • Source: BSE

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 23, 2026 for...

23 Feb, 2026 | 04:18pm • Source: BSE

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 16, 2026 for...

17 Feb, 2026 | 10:22am • Source: BSE

Pls find enclosed Clarification on Market Rumour.

10 Feb, 2026 | 10:18am • Source: BSE

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 06, 2026 for...

06 Feb, 2026 | 05:31pm • Source: BSE

Pls find enclosed Earnings Call Transcript

05 Feb, 2026 | 11:05am • Source: BSE

Ajanta Pharma Limited has informed the Exchange about Copy of Newspaper Publication

02 Feb, 2026 | 11:11am • Source: NSE

Pls find enclosed intimation w.r.t Participation in Investor Conference

02 Feb, 2026 | 10:51am • Source: BSE

Pls find enclosed newspaper cuttings of Financial results published.

02 Feb, 2026 | 10:32am • Source: BSE

Pls find enclosed Intimation of vesting of SARs and cancellation of ESOPs

30 Jan, 2026 | 03:18pm • Source: BSE

Pls find enclosed Board Meeting Outcome

30 Jan, 2026 | 03:07pm • Source: BSE

Pls find enclosed results for quarter ended 31st December 2025.

30 Jan, 2026 | 03:03pm • Source: BSE